Marian Rewers
Concepts (925)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 387 | 2026 | 3788 | 20.920 |
Why?
| | Autoimmunity | 132 | 2025 | 906 | 11.920 |
Why?
| | Islets of Langerhans | 120 | 2025 | 803 | 11.680 |
Why?
| | Autoantibodies | 187 | 2026 | 1474 | 11.460 |
Why?
| | Celiac Disease | 53 | 2026 | 295 | 7.170 |
Why?
| | Genetic Predisposition to Disease | 96 | 2026 | 2368 | 4.360 |
Why?
| | Coronary Artery Disease | 34 | 2018 | 702 | 3.350 |
Why?
| | Diabetic Angiopathies | 28 | 2017 | 250 | 3.140 |
Why?
| | HLA-DQ Antigens | 38 | 2025 | 178 | 2.990 |
Why?
| | Child, Preschool | 207 | 2026 | 11462 | 2.990 |
Why?
| | Calcinosis | 23 | 2015 | 238 | 2.820 |
Why?
| | Child | 238 | 2026 | 22313 | 2.800 |
Why?
| | HLA-DR Antigens | 28 | 2021 | 227 | 2.690 |
Why?
| | Insulin Resistance | 55 | 2018 | 1218 | 2.590 |
Why?
| | Insulin | 75 | 2026 | 2458 | 2.510 |
Why?
| | Disease Progression | 82 | 2025 | 2791 | 2.430 |
Why?
| | Infant | 167 | 2025 | 9790 | 2.390 |
Why?
| | Risk Factors | 164 | 2026 | 10430 | 2.280 |
Why?
| | Humans | 508 | 2026 | 140898 | 2.150 |
Why?
| | Polymorphism, Single Nucleotide | 39 | 2026 | 2128 | 2.060 |
Why?
| | Blood Glucose | 38 | 2022 | 2273 | 2.050 |
Why?
| | Transglutaminases | 29 | 2024 | 156 | 2.020 |
Why?
| | Genotype | 63 | 2026 | 1862 | 2.000 |
Why?
| | Autoimmune Diseases | 17 | 2026 | 465 | 2.000 |
Why?
| | Diabetic Ketoacidosis | 15 | 2026 | 209 | 1.970 |
Why?
| | Male | 344 | 2026 | 69893 | 1.930 |
Why?
| | Prospective Studies | 100 | 2025 | 7749 | 1.910 |
Why?
| | Insulin Antibodies | 24 | 2026 | 103 | 1.880 |
Why?
| | Female | 352 | 2026 | 75540 | 1.870 |
Why?
| | Adolescent | 145 | 2026 | 22027 | 1.830 |
Why?
| | Biomarkers | 48 | 2026 | 4175 | 1.790 |
Why?
| | Mass Screening | 23 | 2026 | 1300 | 1.740 |
Why?
| | Glutamate Decarboxylase | 35 | 2025 | 166 | 1.670 |
Why?
| | Hyperglycemia | 11 | 2026 | 363 | 1.630 |
Why?
| | Diabetic Nephropathies | 19 | 2020 | 293 | 1.630 |
Why?
| | Insulin-Secreting Cells | 15 | 2023 | 380 | 1.500 |
Why?
| | Coronary Disease | 15 | 2010 | 370 | 1.460 |
Why?
| | Prediabetic State | 14 | 2023 | 251 | 1.430 |
Why?
| | Diet | 29 | 2024 | 1269 | 1.350 |
Why?
| | Case-Control Studies | 57 | 2023 | 3578 | 1.300 |
Why?
| | HLA Antigens | 24 | 2025 | 234 | 1.220 |
Why?
| | Follow-Up Studies | 63 | 2025 | 5194 | 1.210 |
Why?
| | Health Care Costs | 2 | 2025 | 418 | 1.210 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 10 | 2022 | 50 | 1.200 |
Why?
| | Glutens | 11 | 2023 | 59 | 1.180 |
Why?
| | Diabetes Mellitus, Type 2 | 36 | 2025 | 2524 | 1.150 |
Why?
| | Cohort Studies | 67 | 2025 | 5789 | 1.120 |
Why?
| | Fatty Acids, Omega-3 | 8 | 2020 | 142 | 1.110 |
Why?
| | Enterovirus Infections | 6 | 2023 | 172 | 1.070 |
Why?
| | Adult | 161 | 2026 | 39134 | 1.060 |
Why?
| | HLA-DR3 Antigen | 17 | 2025 | 78 | 1.050 |
Why?
| | Polymorphism, Genetic | 15 | 2019 | 624 | 1.040 |
Why?
| | Environment | 5 | 2018 | 341 | 1.020 |
Why?
| | Infant, Newborn | 66 | 2025 | 6257 | 0.980 |
Why?
| | H(+)-K(+)-Exchanging ATPase | 2 | 2017 | 8 | 0.970 |
Why?
| | Erythrocyte Membrane | 5 | 2015 | 53 | 0.960 |
Why?
| | HLA-DR4 Antigen | 17 | 2025 | 77 | 0.910 |
Why?
| | Atherosclerosis | 15 | 2018 | 402 | 0.910 |
Why?
| | Middle Aged | 137 | 2025 | 34487 | 0.880 |
Why?
| | Colorado | 44 | 2024 | 4597 | 0.880 |
Why?
| | Diabetes Complications | 7 | 2019 | 222 | 0.840 |
Why?
| | Incidence | 36 | 2022 | 2782 | 0.840 |
Why?
| | Coronary Vessels | 8 | 2017 | 247 | 0.840 |
Why?
| | Albuminuria | 12 | 2016 | 185 | 0.830 |
Why?
| | Enterovirus | 5 | 2019 | 85 | 0.830 |
Why?
| | Longitudinal Studies | 29 | 2025 | 2920 | 0.830 |
Why?
| | Age of Onset | 19 | 2026 | 533 | 0.820 |
Why?
| | DNA Methylation | 6 | 2025 | 640 | 0.800 |
Why?
| | Proportional Hazards Models | 26 | 2024 | 1261 | 0.800 |
Why?
| | Vascular Calcification | 9 | 2018 | 111 | 0.780 |
Why?
| | Predictive Value of Tests | 25 | 2019 | 2062 | 0.750 |
Why?
| | Young Adult | 53 | 2026 | 13646 | 0.730 |
Why?
| | Glucose Tolerance Test | 26 | 2022 | 367 | 0.710 |
Why?
| | C-Peptide | 7 | 2025 | 167 | 0.700 |
Why?
| | Breast Feeding | 18 | 2021 | 442 | 0.680 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 12 | 2025 | 54 | 0.680 |
Why?
| | Haplotypes | 15 | 2026 | 499 | 0.670 |
Why?
| | Genetic Testing | 8 | 2019 | 463 | 0.670 |
Why?
| | Fatty Acids | 6 | 2021 | 448 | 0.660 |
Why?
| | Calcium | 8 | 2023 | 1190 | 0.650 |
Why?
| | Zinc Transporter 8 | 8 | 2025 | 63 | 0.650 |
Why?
| | Blood Glucose Self-Monitoring | 6 | 2022 | 704 | 0.640 |
Why?
| | Antibodies, Viral | 6 | 2023 | 652 | 0.630 |
Why?
| | Autoantigens | 9 | 2025 | 425 | 0.620 |
Why?
| | Vitamin D | 7 | 2018 | 392 | 0.610 |
Why?
| | Inflammation | 9 | 2026 | 2891 | 0.570 |
Why?
| | Prevalence | 23 | 2024 | 2780 | 0.570 |
Why?
| | Early Diagnosis | 7 | 2025 | 242 | 0.570 |
Why?
| | Infant Nutritional Physiological Phenomena | 5 | 2021 | 144 | 0.570 |
Why?
| | Seroconversion | 6 | 2021 | 45 | 0.570 |
Why?
| | Uric Acid | 6 | 2018 | 164 | 0.570 |
Why?
| | Cross-Sectional Studies | 36 | 2025 | 5645 | 0.560 |
Why?
| | GTP-Binding Proteins | 7 | 2024 | 151 | 0.550 |
Why?
| | Body Mass Index | 23 | 2025 | 2374 | 0.550 |
Why?
| | Germany | 12 | 2024 | 131 | 0.540 |
Why?
| | Infant Food | 7 | 2018 | 64 | 0.530 |
Why?
| | Logistic Models | 24 | 2017 | 2088 | 0.530 |
Why?
| | Adiponectin | 5 | 2016 | 243 | 0.520 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2016 | 97 | 0.520 |
Why?
| | Smoking | 9 | 2025 | 1573 | 0.520 |
Why?
| | Sensitivity and Specificity | 22 | 2026 | 1968 | 0.510 |
Why?
| | Edible Grain | 4 | 2008 | 47 | 0.510 |
Why?
| | Finland | 16 | 2025 | 81 | 0.510 |
Why?
| | Fibrinogen | 5 | 2019 | 180 | 0.510 |
Why?
| | Metabolomics | 5 | 2021 | 702 | 0.500 |
Why?
| | Glomerular Filtration Rate | 15 | 2020 | 752 | 0.500 |
Why?
| | Monitoring, Physiologic | 2 | 2009 | 285 | 0.500 |
Why?
| | Age Factors | 38 | 2026 | 3278 | 0.490 |
Why?
| | Arteriosclerosis | 17 | 2004 | 83 | 0.490 |
Why?
| | Genome-Wide Association Study | 10 | 2026 | 1403 | 0.480 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2013 | 438 | 0.480 |
Why?
| | Hypoglycemia | 5 | 2014 | 467 | 0.470 |
Why?
| | Lipids | 5 | 2019 | 689 | 0.470 |
Why?
| | Triglycerides | 13 | 2020 | 511 | 0.460 |
Why?
| | Hypertension | 11 | 2021 | 1251 | 0.460 |
Why?
| | Luminescent Measurements | 4 | 2021 | 74 | 0.450 |
Why?
| | Milk | 7 | 2017 | 123 | 0.450 |
Why?
| | Environmental Exposure | 4 | 2025 | 578 | 0.450 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2025 | 656 | 0.450 |
Why?
| | Probiotics | 3 | 2022 | 57 | 0.440 |
Why?
| | C-Reactive Protein | 5 | 2018 | 416 | 0.440 |
Why?
| | Helicobacter Infections | 1 | 2014 | 29 | 0.440 |
Why?
| | Helicobacter pylori | 1 | 2014 | 43 | 0.430 |
Why?
| | Respiratory Tract Infections | 5 | 2025 | 383 | 0.430 |
Why?
| | Risk | 17 | 2020 | 903 | 0.430 |
Why?
| | Time Factors | 21 | 2018 | 6944 | 0.420 |
Why?
| | Antibodies | 5 | 2024 | 411 | 0.420 |
Why?
| | Asymptomatic Diseases | 3 | 2023 | 92 | 0.410 |
Why?
| | Dietary Supplements | 7 | 2024 | 566 | 0.410 |
Why?
| | Fatty Acids, Monounsaturated | 2 | 2014 | 54 | 0.410 |
Why?
| | Sweden | 13 | 2024 | 104 | 0.410 |
Why?
| | Fatty Acid Desaturases | 1 | 2013 | 31 | 0.410 |
Why?
| | Immunogenetics | 1 | 2013 | 7 | 0.400 |
Why?
| | Dyslipidemias | 4 | 2015 | 175 | 0.400 |
Why?
| | Alleles | 14 | 2021 | 883 | 0.400 |
Why?
| | Risk Assessment | 17 | 2021 | 3484 | 0.400 |
Why?
| | Glucose Clamp Technique | 8 | 2020 | 197 | 0.390 |
Why?
| | Proteomics | 6 | 2025 | 1136 | 0.390 |
Why?
| | United States | 35 | 2025 | 15195 | 0.390 |
Why?
| | Prognosis | 17 | 2021 | 4060 | 0.390 |
Why?
| | Bacteriophages | 2 | 2025 | 106 | 0.380 |
Why?
| | HLA-D Antigens | 5 | 2019 | 32 | 0.380 |
Why?
| | Dietary Fats | 3 | 2014 | 299 | 0.380 |
Why?
| | Oxylipins | 3 | 2023 | 41 | 0.380 |
Why?
| | Child Nutritional Physiological Phenomena | 4 | 2019 | 107 | 0.370 |
Why?
| | Cost-Benefit Analysis | 4 | 2026 | 609 | 0.370 |
Why?
| | Fasting | 12 | 2015 | 283 | 0.370 |
Why?
| | Epitopes | 6 | 2025 | 477 | 0.370 |
Why?
| | Vitamin D Deficiency | 2 | 2011 | 187 | 0.360 |
Why?
| | Lipoproteins | 4 | 2015 | 163 | 0.360 |
Why?
| | Apolipoproteins A | 2 | 2006 | 18 | 0.360 |
Why?
| | Ascorbic Acid | 4 | 2023 | 179 | 0.360 |
Why?
| | Liver | 3 | 2012 | 1815 | 0.350 |
Why?
| | Addison Disease | 6 | 2012 | 42 | 0.350 |
Why?
| | Major Histocompatibility Complex | 6 | 2026 | 234 | 0.350 |
Why?
| | Sex Factors | 20 | 2020 | 2051 | 0.340 |
Why?
| | Life Style | 5 | 2015 | 478 | 0.340 |
Why?
| | Adipocytes | 1 | 2012 | 220 | 0.340 |
Why?
| | Fetal Blood | 6 | 2021 | 336 | 0.340 |
Why?
| | Hypoglycemic Agents | 8 | 2020 | 1368 | 0.330 |
Why?
| | Hypolipidemic Agents | 2 | 2010 | 92 | 0.330 |
Why?
| | Dietary Proteins | 4 | 2019 | 135 | 0.330 |
Why?
| | Cholesterol, HDL | 8 | 2015 | 196 | 0.330 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 712 | 0.330 |
Why?
| | Precision Medicine | 1 | 2014 | 433 | 0.320 |
Why?
| | Plant Proteins | 1 | 2011 | 111 | 0.320 |
Why?
| | Epidemics | 1 | 2011 | 92 | 0.320 |
Why?
| | Research | 2 | 2013 | 431 | 0.320 |
Why?
| | Surveys and Questionnaires | 17 | 2024 | 5931 | 0.320 |
Why?
| | Eating | 5 | 2023 | 391 | 0.320 |
Why?
| | Patient Education as Topic | 2 | 2005 | 772 | 0.320 |
Why?
| | Blood Proteins | 3 | 2017 | 250 | 0.310 |
Why?
| | Steroid 21-Hydroxylase | 5 | 2012 | 29 | 0.310 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2025 | 1112 | 0.310 |
Why?
| | Cesarean Section | 2 | 2024 | 213 | 0.310 |
Why?
| | HLA-DQ beta-Chains | 12 | 2019 | 62 | 0.310 |
Why?
| | Obesity | 12 | 2015 | 3000 | 0.310 |
Why?
| | CTLA-4 Antigen | 5 | 2017 | 102 | 0.310 |
Why?
| | Cystatin C | 6 | 2014 | 65 | 0.310 |
Why?
| | Family Health | 8 | 2017 | 194 | 0.300 |
Why?
| | Clinical Trials as Topic | 3 | 2009 | 1031 | 0.300 |
Why?
| | Multivariate Analysis | 10 | 2016 | 1496 | 0.300 |
Why?
| | Diet, Ketogenic | 1 | 2009 | 36 | 0.290 |
Why?
| | Gastrointestinal Microbiome | 3 | 2025 | 720 | 0.290 |
Why?
| | Sex Distribution | 6 | 2011 | 381 | 0.290 |
Why?
| | Rotavirus | 2 | 2016 | 20 | 0.290 |
Why?
| | Antigens, CD | 2 | 2009 | 544 | 0.280 |
Why?
| | Reproductive History | 1 | 2008 | 12 | 0.280 |
Why?
| | Feces | 7 | 2025 | 493 | 0.280 |
Why?
| | Europe | 11 | 2021 | 406 | 0.280 |
Why?
| | Diabetes Mellitus | 8 | 2009 | 1072 | 0.280 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2007 | 7 | 0.270 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.270 |
Why?
| | Adiposity | 7 | 2020 | 518 | 0.270 |
Why?
| | Pregnancy | 18 | 2025 | 7035 | 0.270 |
Why?
| | Reference Values | 10 | 2012 | 803 | 0.270 |
Why?
| | Seroepidemiologic Studies | 4 | 2023 | 167 | 0.270 |
Why?
| | Diet, Gluten-Free | 3 | 2024 | 48 | 0.270 |
Why?
| | Iron | 3 | 2023 | 323 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 12 | 2018 | 2760 | 0.260 |
Why?
| | Proteome | 2 | 2025 | 483 | 0.260 |
Why?
| | Gene-Environment Interaction | 5 | 2024 | 187 | 0.260 |
Why?
| | Survival Analysis | 4 | 2021 | 1320 | 0.260 |
Why?
| | Glycopeptides | 2 | 2018 | 44 | 0.260 |
Why?
| | Adipose Tissue | 4 | 2018 | 645 | 0.260 |
Why?
| | Metabolome | 2 | 2020 | 366 | 0.250 |
Why?
| | Exercise | 4 | 2023 | 2108 | 0.250 |
Why?
| | HLA-DRB1 Chains | 8 | 2019 | 111 | 0.250 |
Why?
| | Renin-Angiotensin System | 1 | 2007 | 77 | 0.250 |
Why?
| | RNA, Viral | 3 | 2019 | 691 | 0.250 |
Why?
| | Rotavirus Infections | 1 | 2006 | 39 | 0.250 |
Why?
| | Histocompatibility Antigens Class I | 5 | 2011 | 208 | 0.250 |
Why?
| | Patient Compliance | 3 | 2023 | 607 | 0.250 |
Why?
| | Overweight | 3 | 2021 | 587 | 0.250 |
Why?
| | Apolipoproteins C | 1 | 2006 | 4 | 0.250 |
Why?
| | Remission Induction | 2 | 2004 | 309 | 0.250 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 197 | 0.250 |
Why?
| | HLA-DR alpha-Chains | 1 | 2026 | 5 | 0.250 |
Why?
| | Complement C4a | 1 | 2026 | 9 | 0.250 |
Why?
| | Regression Analysis | 15 | 2014 | 1015 | 0.240 |
Why?
| | Contraception | 1 | 2008 | 165 | 0.240 |
Why?
| | Infant Formula | 3 | 2019 | 71 | 0.240 |
Why?
| | Cardiovascular Diseases | 8 | 2018 | 2082 | 0.240 |
Why?
| | Protein Tyrosine Phosphatases | 7 | 2006 | 168 | 0.240 |
Why?
| | Receptors, Interleukin-2 | 1 | 2005 | 65 | 0.240 |
Why?
| | Aged | 45 | 2021 | 24666 | 0.240 |
Why?
| | Quantitative Trait Loci | 2 | 2025 | 364 | 0.230 |
Why?
| | Chromosome Mapping | 4 | 2025 | 504 | 0.230 |
Why?
| | Carotid Arteries | 5 | 1998 | 201 | 0.230 |
Why?
| | Hypersensitivity, Immediate | 1 | 2025 | 43 | 0.230 |
Why?
| | Gene Frequency | 10 | 2020 | 492 | 0.230 |
Why?
| | Maternal Age | 3 | 2004 | 128 | 0.230 |
Why?
| | Diet Records | 4 | 2019 | 83 | 0.230 |
Why?
| | Proinsulin | 3 | 2014 | 52 | 0.230 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2025 | 14 | 0.230 |
Why?
| | Histocompatibility Antigens Class II | 5 | 2011 | 369 | 0.230 |
Why?
| | Glucose Intolerance | 7 | 2013 | 147 | 0.230 |
Why?
| | Apolipoproteins | 3 | 2014 | 36 | 0.230 |
Why?
| | Tobacco Smoke Pollution | 4 | 2019 | 238 | 0.220 |
Why?
| | Plasminogen Activator Inhibitor 1 | 6 | 2017 | 89 | 0.220 |
Why?
| | Introns | 1 | 2026 | 253 | 0.220 |
Why?
| | Abdominal Wall | 1 | 2004 | 26 | 0.220 |
Why?
| | Mass Spectrometry | 4 | 2025 | 740 | 0.220 |
Why?
| | Linear Models | 7 | 2016 | 854 | 0.220 |
Why?
| | Immunotherapy | 1 | 2009 | 643 | 0.220 |
Why?
| | Docosahexaenoic Acids | 3 | 2021 | 86 | 0.220 |
Why?
| | Antihypertensive Agents | 2 | 2007 | 507 | 0.220 |
Why?
| | Health Surveys | 3 | 2018 | 511 | 0.220 |
Why?
| | Hyperlipidemias | 1 | 2005 | 125 | 0.220 |
Why?
| | Inflammation Mediators | 2 | 2026 | 517 | 0.210 |
Why?
| | Immunoglobulin A | 6 | 2024 | 214 | 0.210 |
Why?
| | Fever | 1 | 2025 | 308 | 0.210 |
Why?
| | Animals | 26 | 2022 | 37579 | 0.210 |
Why?
| | Bone Density | 2 | 2020 | 495 | 0.210 |
Why?
| | Delivery, Obstetric | 2 | 2004 | 162 | 0.210 |
Why?
| | Haptoglobins | 3 | 2013 | 56 | 0.210 |
Why?
| | Seasons | 5 | 2024 | 542 | 0.210 |
Why?
| | Vitamin B Complex | 1 | 2024 | 40 | 0.210 |
Why?
| | Electrochemical Techniques | 2 | 2021 | 53 | 0.210 |
Why?
| | Coronary Angiography | 2 | 2014 | 316 | 0.210 |
Why?
| | Peptide Library | 1 | 2024 | 95 | 0.200 |
Why?
| | Alanine Transaminase | 2 | 2015 | 150 | 0.200 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2026 | 851 | 0.200 |
Why?
| | Birth Weight | 4 | 2016 | 511 | 0.200 |
Why?
| | Genetic Variation | 3 | 2021 | 994 | 0.200 |
Why?
| | Iron Overload | 1 | 2023 | 18 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2025 | 153 | 0.200 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 389 | 0.200 |
Why?
| | Muscle, Skeletal | 2 | 2018 | 1750 | 0.200 |
Why?
| | Child Development | 2 | 2020 | 496 | 0.200 |
Why?
| | Virus Diseases | 4 | 2021 | 215 | 0.190 |
Why?
| | ROC Curve | 4 | 2019 | 589 | 0.190 |
Why?
| | Ketone Bodies | 2 | 2014 | 14 | 0.190 |
Why?
| | Kaplan-Meier Estimate | 4 | 2018 | 907 | 0.190 |
Why?
| | Alcohol Drinking | 1 | 2009 | 833 | 0.190 |
Why?
| | Complement System Proteins | 1 | 2025 | 332 | 0.190 |
Why?
| | Pediatrics | 4 | 2020 | 1097 | 0.190 |
Why?
| | Diabetic Retinopathy | 4 | 2016 | 201 | 0.190 |
Why?
| | Costs and Cost Analysis | 2 | 2020 | 219 | 0.190 |
Why?
| | Micronutrients | 2 | 2017 | 92 | 0.180 |
Why?
| | Lipid Metabolism | 2 | 2019 | 525 | 0.180 |
Why?
| | Mothers | 4 | 2021 | 777 | 0.180 |
Why?
| | Influenza, Human | 2 | 2022 | 625 | 0.180 |
Why?
| | Peptides | 3 | 2024 | 979 | 0.180 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2021 | 180 | 0.180 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 449 | 0.180 |
Why?
| | Blood Pressure | 9 | 2014 | 1745 | 0.180 |
Why?
| | Age Distribution | 5 | 2011 | 397 | 0.180 |
Why?
| | Lipase | 1 | 2002 | 68 | 0.180 |
Why?
| | Odds Ratio | 6 | 2015 | 1054 | 0.180 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2021 | 13 | 0.180 |
Why?
| | T-Lymphocytes | 3 | 2025 | 2003 | 0.180 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 48 | 0.180 |
Why?
| | Reproducibility of Results | 9 | 2021 | 3336 | 0.180 |
Why?
| | Monitoring, Ambulatory | 2 | 2014 | 90 | 0.180 |
Why?
| | Glycerol | 2 | 2012 | 91 | 0.180 |
Why?
| | Parents | 6 | 2023 | 1440 | 0.180 |
Why?
| | Receptors, Calcitriol | 2 | 2012 | 55 | 0.180 |
Why?
| | Growth | 2 | 2016 | 52 | 0.180 |
Why?
| | Body Height | 3 | 2014 | 200 | 0.180 |
Why?
| | Promoter Regions, Genetic | 2 | 2006 | 1241 | 0.180 |
Why?
| | White Matter | 1 | 2023 | 147 | 0.170 |
Why?
| | Polysaccharides | 2 | 2022 | 87 | 0.170 |
Why?
| | Gestational Age | 3 | 2020 | 952 | 0.170 |
Why?
| | Bacteria | 2 | 2025 | 874 | 0.170 |
Why?
| | F2-Isoprostanes | 2 | 2015 | 21 | 0.170 |
Why?
| | Gastroenteritis | 2 | 2016 | 68 | 0.170 |
Why?
| | Luminescence | 3 | 2016 | 37 | 0.170 |
Why?
| | HLA-B8 Antigen | 4 | 2012 | 12 | 0.170 |
Why?
| | Vitamins | 2 | 2020 | 181 | 0.170 |
Why?
| | Ketosis | 1 | 2020 | 12 | 0.170 |
Why?
| | Genomics | 2 | 2021 | 810 | 0.160 |
Why?
| | Influenza Vaccines | 2 | 2017 | 551 | 0.160 |
Why?
| | Neonatal Screening | 4 | 2020 | 172 | 0.160 |
Why?
| | Dietary Sucrose | 1 | 2020 | 48 | 0.160 |
Why?
| | Dietary Carbohydrates | 2 | 2015 | 152 | 0.160 |
Why?
| | Disease Susceptibility | 6 | 2020 | 352 | 0.160 |
Why?
| | Biopsy | 5 | 2017 | 1069 | 0.160 |
Why?
| | Cytokines | 5 | 2026 | 2092 | 0.160 |
Why?
| | Mannose | 1 | 2019 | 24 | 0.160 |
Why?
| | Sugars | 1 | 2020 | 41 | 0.160 |
Why?
| | Prodromal Symptoms | 1 | 2020 | 19 | 0.160 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 112 | 0.160 |
Why?
| | Mice, Inbred NOD | 5 | 2015 | 599 | 0.160 |
Why?
| | Life Change Events | 1 | 2021 | 151 | 0.160 |
Why?
| | Energy Intake | 5 | 2023 | 510 | 0.160 |
Why?
| | Adenosine Diphosphate | 1 | 2019 | 82 | 0.160 |
Why?
| | Interferon-gamma | 2 | 2021 | 789 | 0.150 |
Why?
| | Kidney | 2 | 2018 | 1475 | 0.150 |
Why?
| | Developing Countries | 2 | 1993 | 307 | 0.150 |
Why?
| | Phospholipids | 1 | 2021 | 221 | 0.150 |
Why?
| | Metabolic Clearance Rate | 3 | 2014 | 116 | 0.150 |
Why?
| | Oxidative Stress | 3 | 2017 | 1325 | 0.150 |
Why?
| | Cation Transport Proteins | 3 | 2011 | 109 | 0.150 |
Why?
| | Epidemiologic Methods | 4 | 2014 | 94 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2003 | 406 | 0.150 |
Why?
| | Apolipoproteins B | 2 | 2015 | 45 | 0.150 |
Why?
| | Butyrates | 1 | 2019 | 61 | 0.150 |
Why?
| | Iodide Peroxidase | 5 | 2025 | 34 | 0.150 |
Why?
| | Measles | 1 | 2019 | 48 | 0.150 |
Why?
| | Osteoporotic Fractures | 1 | 2020 | 61 | 0.150 |
Why?
| | Glycosuria | 2 | 2009 | 10 | 0.150 |
Why?
| | Fatty Acids, Omega-6 | 4 | 2020 | 48 | 0.150 |
Why?
| | Cotinine | 1 | 2019 | 78 | 0.150 |
Why?
| | Antibodies, Bacterial | 1 | 2019 | 145 | 0.150 |
Why?
| | Uromodulin | 1 | 2018 | 20 | 0.150 |
Why?
| | Genes, MHC Class II | 3 | 2012 | 75 | 0.150 |
Why?
| | Genetic Markers | 4 | 2013 | 342 | 0.150 |
Why?
| | Cholesterol | 5 | 2014 | 404 | 0.150 |
Why?
| | Mexican Americans | 3 | 2014 | 112 | 0.140 |
Why?
| | Health Expenditures | 1 | 2020 | 193 | 0.140 |
Why?
| | Models, Biological | 5 | 2019 | 1822 | 0.140 |
Why?
| | HLA-DP beta-Chains | 3 | 2015 | 91 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2021 | 260 | 0.140 |
Why?
| | Self Report | 3 | 2020 | 858 | 0.140 |
Why?
| | Squalene | 1 | 2017 | 8 | 0.140 |
Why?
| | HLA-DR2 Antigen | 2 | 2012 | 7 | 0.140 |
Why?
| | Sodium Bicarbonate | 1 | 2018 | 45 | 0.140 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.140 |
Why?
| | Amino Acid Sequence | 6 | 2024 | 2152 | 0.140 |
Why?
| | High-Throughput Screening Assays | 1 | 2019 | 157 | 0.140 |
Why?
| | Phenotype | 8 | 2024 | 3172 | 0.130 |
Why?
| | Antipyretics | 1 | 2017 | 5 | 0.130 |
Why?
| | Cost of Illness | 1 | 2020 | 310 | 0.130 |
Why?
| | Feeding Behavior | 3 | 2013 | 679 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2019 | 374 | 0.130 |
Why?
| | Immunologic Memory | 1 | 2019 | 359 | 0.130 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1761 | 0.130 |
Why?
| | Radioimmunoassay | 6 | 2016 | 169 | 0.130 |
Why?
| | Blood Cell Count | 1 | 2017 | 54 | 0.130 |
Why?
| | Immunization | 1 | 1999 | 405 | 0.130 |
Why?
| | Body Composition | 3 | 2020 | 703 | 0.130 |
Why?
| | Rheumatoid Factor | 3 | 2007 | 177 | 0.130 |
Why?
| | Kidney Diseases | 2 | 2012 | 408 | 0.130 |
Why?
| | Models, Genetic | 2 | 2017 | 587 | 0.130 |
Why?
| | Genetic Loci | 3 | 2015 | 276 | 0.130 |
Why?
| | Rural Health | 2 | 2002 | 83 | 0.130 |
Why?
| | Osteoporosis | 1 | 2020 | 242 | 0.130 |
Why?
| | Patient Care Planning | 2 | 2015 | 153 | 0.130 |
Why?
| | Poland | 4 | 2010 | 35 | 0.130 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 59 | 0.130 |
Why?
| | Milk Proteins | 1 | 1996 | 35 | 0.130 |
Why?
| | Toxins, Biological | 1 | 2016 | 12 | 0.130 |
Why?
| | Homozygote | 5 | 2014 | 201 | 0.120 |
Why?
| | Immunoglobulin G | 4 | 2021 | 897 | 0.120 |
Why?
| | Models, Theoretical | 2 | 2017 | 580 | 0.120 |
Why?
| | Arachidonic Acid | 2 | 2021 | 126 | 0.120 |
Why?
| | Proteins | 2 | 2021 | 1013 | 0.120 |
Why?
| | Body Weight | 3 | 2016 | 992 | 0.120 |
Why?
| | Vitamin B 12 | 1 | 2017 | 125 | 0.120 |
Why?
| | Hygiene | 1 | 2016 | 29 | 0.120 |
Why?
| | HLA-A1 Antigen | 2 | 2006 | 4 | 0.120 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 7 | 2006 | 44 | 0.120 |
Why?
| | HLA-DP Antigens | 2 | 2007 | 33 | 0.120 |
Why?
| | Diet Surveys | 4 | 2021 | 91 | 0.120 |
Why?
| | Anorexia Nervosa | 1 | 2017 | 78 | 0.120 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2017 | 127 | 0.120 |
Why?
| | Polymerase Chain Reaction | 5 | 2011 | 1052 | 0.120 |
Why?
| | Lentigo | 1 | 2015 | 6 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2023 | 1536 | 0.120 |
Why?
| | Feeding Methods | 1 | 2015 | 6 | 0.120 |
Why?
| | Oligonucleotide Array Sequence Analysis | 4 | 2011 | 757 | 0.120 |
Why?
| | Histocompatibility Testing | 6 | 2017 | 123 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2018 | 622 | 0.120 |
Why?
| | Erythrocytes | 1 | 2021 | 707 | 0.110 |
Why?
| | Absorptiometry, Photon | 2 | 2020 | 265 | 0.110 |
Why?
| | Medical Records | 2 | 2007 | 182 | 0.110 |
Why?
| | Stress, Psychological | 2 | 2021 | 1122 | 0.110 |
Why?
| | Complement C3 | 1 | 2016 | 203 | 0.110 |
Why?
| | Dietary Fiber | 1 | 2015 | 57 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 544 | 0.110 |
Why?
| | Carbohydrates | 1 | 2015 | 67 | 0.110 |
Why?
| | Child Day Care Centers | 1 | 2015 | 39 | 0.110 |
Why?
| | Genetic Association Studies | 4 | 2020 | 375 | 0.110 |
Why?
| | Oxygen | 1 | 2020 | 992 | 0.110 |
Why?
| | Periodontal Diseases | 1 | 2015 | 60 | 0.110 |
Why?
| | International Agencies | 1 | 2014 | 32 | 0.110 |
Why?
| | Up-Regulation | 2 | 2016 | 856 | 0.110 |
Why?
| | Gram-Positive Bacteria | 1 | 2014 | 48 | 0.110 |
Why?
| | Fructosamine | 1 | 2014 | 15 | 0.110 |
Why?
| | Video Recording | 2 | 2015 | 197 | 0.110 |
Why?
| | Health Records, Personal | 1 | 2014 | 28 | 0.110 |
Why?
| | Dairy Products | 1 | 2014 | 30 | 0.110 |
Why?
| | Carotid Artery Diseases | 3 | 2000 | 62 | 0.110 |
Why?
| | Societies, Scientific | 1 | 2014 | 50 | 0.110 |
Why?
| | Genetic Linkage | 2 | 2015 | 288 | 0.110 |
Why?
| | Adolescent Medicine | 1 | 2014 | 29 | 0.110 |
Why?
| | Acetaminophen | 1 | 2017 | 264 | 0.110 |
Why?
| | Gram-Negative Bacteria | 1 | 2014 | 79 | 0.110 |
Why?
| | Molecular Sequence Data | 7 | 2015 | 2917 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 348 | 0.110 |
Why?
| | Bias | 1 | 2015 | 208 | 0.110 |
Why?
| | Renal Insufficiency | 1 | 2016 | 169 | 0.110 |
Why?
| | Eicosapentaenoic Acid | 1 | 2013 | 38 | 0.100 |
Why?
| | Cholesterol, Dietary | 1 | 2013 | 15 | 0.100 |
Why?
| | Hemodynamics | 1 | 2018 | 1100 | 0.100 |
Why?
| | Gene Expression | 3 | 2021 | 1490 | 0.100 |
Why?
| | Siblings | 3 | 2018 | 216 | 0.100 |
Why?
| | Eggs | 1 | 2013 | 29 | 0.100 |
Why?
| | Creatinine | 4 | 2018 | 490 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 179 | 0.100 |
Why?
| | Epigenesis, Genetic | 3 | 2024 | 655 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 325 | 0.100 |
Why?
| | Heart Rate | 3 | 2010 | 821 | 0.100 |
Why?
| | Research Support as Topic | 1 | 2013 | 81 | 0.100 |
Why?
| | Hypoxia | 1 | 2020 | 1164 | 0.100 |
Why?
| | Mice | 11 | 2022 | 18057 | 0.100 |
Why?
| | Biological Specimen Banks | 1 | 2013 | 99 | 0.100 |
Why?
| | Communicable Diseases | 1 | 2015 | 161 | 0.100 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.100 |
Why?
| | Monoamine Oxidase | 1 | 2012 | 28 | 0.100 |
Why?
| | Anesthesiology | 1 | 2015 | 170 | 0.090 |
Why?
| | Organizational Innovation | 1 | 2013 | 128 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2023 | 719 | 0.090 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 2009 | 28 | 0.090 |
Why?
| | Immunity, Innate | 2 | 2022 | 852 | 0.090 |
Why?
| | History, 21st Century | 1 | 2013 | 218 | 0.090 |
Why?
| | Sex Characteristics | 7 | 2015 | 785 | 0.090 |
Why?
| | Stomach | 1 | 2012 | 109 | 0.090 |
Why?
| | Epistasis, Genetic | 1 | 2012 | 68 | 0.090 |
Why?
| | CpG Islands | 2 | 2023 | 163 | 0.090 |
Why?
| | Pilot Projects | 4 | 2023 | 1815 | 0.090 |
Why?
| | Specimen Handling | 1 | 2013 | 179 | 0.090 |
Why?
| | Interleukin-4 | 2 | 2005 | 215 | 0.090 |
Why?
| | History, 20th Century | 1 | 2013 | 325 | 0.090 |
Why?
| | Nuclear Family | 2 | 2009 | 57 | 0.090 |
Why?
| | Intestine, Small | 2 | 2005 | 157 | 0.090 |
Why?
| | Consensus | 2 | 2024 | 545 | 0.090 |
Why?
| | Histocompatibility Antigens | 2 | 2013 | 108 | 0.090 |
Why?
| | Hyperinsulinism | 2 | 2010 | 114 | 0.090 |
Why?
| | Lymphocytes | 1 | 2014 | 394 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 873 | 0.090 |
Why?
| | Intestines | 1 | 2014 | 355 | 0.090 |
Why?
| | Calcifediol | 1 | 2011 | 32 | 0.090 |
Why?
| | Patient Selection | 3 | 2011 | 684 | 0.090 |
Why?
| | Pedigree | 4 | 2017 | 511 | 0.090 |
Why?
| | Primary Prevention | 1 | 2013 | 201 | 0.090 |
Why?
| | Gliadin | 2 | 2009 | 12 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1240 | 0.090 |
Why?
| | Toll-Like Receptors | 1 | 2012 | 189 | 0.090 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 23 | 0.090 |
Why?
| | HLA-B Antigens | 1 | 2011 | 60 | 0.090 |
Why?
| | Vitamin D-Binding Protein | 1 | 2010 | 15 | 0.090 |
Why?
| | Kidney Function Tests | 1 | 2011 | 158 | 0.090 |
Why?
| | Vascular Diseases | 2 | 2013 | 244 | 0.080 |
Why?
| | Thyroglobulin | 3 | 2025 | 27 | 0.080 |
Why?
| | Interleukin-2 | 1 | 2012 | 451 | 0.080 |
Why?
| | Vaccines | 1 | 2016 | 405 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2017 | 2056 | 0.080 |
Why?
| | Viruses | 1 | 2013 | 163 | 0.080 |
Why?
| | Endocrine Cells | 1 | 2010 | 7 | 0.080 |
Why?
| | Weight Gain | 2 | 2011 | 537 | 0.080 |
Why?
| | Food, Fortified | 1 | 2010 | 42 | 0.080 |
Why?
| | Linkage Disequilibrium | 4 | 2015 | 254 | 0.080 |
Why?
| | Decision Support Techniques | 2 | 2013 | 429 | 0.080 |
Why?
| | Gastrointestinal Diseases | 1 | 2012 | 206 | 0.080 |
Why?
| | Milk, Human | 3 | 2018 | 169 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2012 | 386 | 0.080 |
Why?
| | Myocardial Infarction | 2 | 1994 | 1069 | 0.080 |
Why?
| | Nutrition Assessment | 2 | 2015 | 92 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2010 | 158 | 0.080 |
Why?
| | Lymphocyte Activation | 1 | 2014 | 1141 | 0.080 |
Why?
| | Microbiota | 2 | 2014 | 758 | 0.080 |
Why?
| | Family | 5 | 2018 | 677 | 0.080 |
Why?
| | Abdomen | 1 | 2010 | 136 | 0.080 |
Why?
| | Monitoring, Immunologic | 1 | 2009 | 22 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 2 | 2012 | 572 | 0.080 |
Why?
| | Membrane Proteins | 3 | 2002 | 1156 | 0.080 |
Why?
| | Socioeconomic Factors | 5 | 2017 | 1310 | 0.080 |
Why?
| | RNA | 1 | 2016 | 929 | 0.080 |
Why?
| | Transcription Factors | 1 | 2017 | 1703 | 0.080 |
Why?
| | Quality Control | 3 | 2013 | 162 | 0.080 |
Why?
| | Waist-Hip Ratio | 2 | 2009 | 35 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 348 | 0.080 |
Why?
| | Pancreas | 2 | 2023 | 326 | 0.080 |
Why?
| | Homeostasis | 2 | 2010 | 636 | 0.070 |
Why?
| | Bifidobacterium | 2 | 2018 | 21 | 0.070 |
Why?
| | Sequence Analysis, DNA | 3 | 2011 | 817 | 0.070 |
Why?
| | Antigens, Viral | 2 | 2021 | 178 | 0.070 |
Why?
| | Algorithms | 3 | 2026 | 1763 | 0.070 |
Why?
| | Spleen | 1 | 2010 | 522 | 0.070 |
Why?
| | Proteinuria | 1 | 2009 | 99 | 0.070 |
Why?
| | Glycemic Index | 1 | 2008 | 26 | 0.070 |
Why?
| | Isoenzymes | 2 | 2006 | 301 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2016 | 614 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2012 | 777 | 0.070 |
Why?
| | Laboratories | 1 | 2009 | 107 | 0.070 |
Why?
| | DEAD-box RNA Helicases | 1 | 2008 | 86 | 0.070 |
Why?
| | Environmental Monitoring | 1 | 2010 | 369 | 0.070 |
Why?
| | Telomere | 3 | 2022 | 279 | 0.070 |
Why?
| | Disease Outbreaks | 2 | 1991 | 418 | 0.070 |
Why?
| | Angiotensins | 1 | 2007 | 8 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 297 | 0.070 |
Why?
| | Lipoproteins, LDL | 2 | 2008 | 112 | 0.070 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2007 | 23 | 0.070 |
Why?
| | Clinical Competence | 1 | 2015 | 1196 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1856 | 0.070 |
Why?
| | Contraceptive Agents, Female | 1 | 2008 | 79 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2007 | 55 | 0.060 |
Why?
| | Clinical Laboratory Techniques | 1 | 2007 | 96 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 568 | 0.060 |
Why?
| | Pediatric Obesity | 1 | 2014 | 599 | 0.060 |
Why?
| | Antidepressive Agents | 1 | 2009 | 243 | 0.060 |
Why?
| | Insulin Infusion Systems | 2 | 2017 | 466 | 0.060 |
Why?
| | Microsatellite Repeats | 2 | 2009 | 159 | 0.060 |
Why?
| | Drug Utilization | 2 | 2017 | 166 | 0.060 |
Why?
| | Datasets as Topic | 2 | 2018 | 123 | 0.060 |
Why?
| | Wheat Hypersensitivity | 1 | 2006 | 4 | 0.060 |
Why?
| | Physicians | 1 | 2015 | 928 | 0.060 |
Why?
| | Population Surveillance | 3 | 2020 | 479 | 0.060 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2006 | 28 | 0.060 |
Why?
| | Antibody Specificity | 4 | 2011 | 187 | 0.060 |
Why?
| | Apolipoprotein C-III | 1 | 2006 | 12 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2018 | 556 | 0.060 |
Why?
| | Epitope Mapping | 2 | 2024 | 61 | 0.060 |
Why?
| | Birth Order | 2 | 2004 | 13 | 0.060 |
Why?
| | Adenovirus Infections, Human | 1 | 2005 | 15 | 0.060 |
Why?
| | Carrier State | 1 | 2006 | 71 | 0.060 |
Why?
| | Paired Box Transcription Factors | 1 | 2005 | 43 | 0.060 |
Why?
| | Neoplasm Proteins | 2 | 2020 | 433 | 0.060 |
Why?
| | Adenoviruses, Human | 1 | 2005 | 27 | 0.060 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 16 | 0.060 |
Why?
| | Metagenomics | 2 | 2019 | 181 | 0.060 |
Why?
| | Chronic Disease | 4 | 2017 | 1811 | 0.060 |
Why?
| | Codon, Terminator | 1 | 2005 | 25 | 0.060 |
Why?
| | Statistics, Nonparametric | 2 | 2011 | 432 | 0.060 |
Why?
| | Antigens, Differentiation | 1 | 2005 | 83 | 0.060 |
Why?
| | Chromatography, Liquid | 3 | 2012 | 453 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2006 | 309 | 0.060 |
Why?
| | Codon, Nonsense | 1 | 2005 | 43 | 0.060 |
Why?
| | Protective Factors | 2 | 2015 | 96 | 0.060 |
Why?
| | Capsid Proteins | 1 | 2005 | 95 | 0.060 |
Why?
| | Fathers | 1 | 2005 | 50 | 0.050 |
Why?
| | Radiography, Abdominal | 1 | 2004 | 44 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4407 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2005 | 149 | 0.050 |
Why?
| | Arthritis, Juvenile | 1 | 2005 | 54 | 0.050 |
Why?
| | Norway | 2 | 2019 | 44 | 0.050 |
Why?
| | Research Design | 3 | 2019 | 1104 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2018 | 545 | 0.050 |
Why?
| | CD3 Complex | 1 | 2024 | 106 | 0.050 |
Why?
| | Survivors | 1 | 2008 | 501 | 0.050 |
Why?
| | Cattle | 3 | 2017 | 991 | 0.050 |
Why?
| | Anthropometry | 1 | 2004 | 208 | 0.050 |
Why?
| | Postmenopause | 3 | 2020 | 369 | 0.050 |
Why?
| | Nutritional Status | 1 | 2007 | 357 | 0.050 |
Why?
| | Transcriptome | 2 | 2023 | 1007 | 0.050 |
Why?
| | Pennsylvania | 2 | 2018 | 134 | 0.050 |
Why?
| | Waist Circumference | 2 | 2015 | 133 | 0.050 |
Why?
| | Registries | 7 | 2019 | 2143 | 0.050 |
Why?
| | Metagenome | 1 | 2025 | 151 | 0.050 |
Why?
| | Insulin, Isophane | 1 | 2003 | 21 | 0.050 |
Why?
| | DNA | 2 | 2011 | 1438 | 0.050 |
Why?
| | Cross-Cultural Comparison | 2 | 2015 | 85 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2004 | 328 | 0.050 |
Why?
| | International Cooperation | 3 | 2016 | 195 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 85 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2022 | 335 | 0.050 |
Why?
| | Iron, Dietary | 1 | 2023 | 22 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2023 | 81 | 0.050 |
Why?
| | Biomedical Research | 1 | 2009 | 680 | 0.050 |
Why?
| | Peptides, Cyclic | 1 | 2005 | 266 | 0.050 |
Why?
| | Computer Simulation | 2 | 2026 | 1011 | 0.050 |
Why?
| | Glycomics | 1 | 2022 | 7 | 0.050 |
Why?
| | Creatine | 1 | 2023 | 62 | 0.050 |
Why?
| | Markov Chains | 2 | 2020 | 123 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 117 | 0.050 |
Why?
| | Observer Variation | 2 | 2015 | 355 | 0.050 |
Why?
| | HLA-DQ alpha-Chains | 2 | 2019 | 16 | 0.050 |
Why?
| | Electrocardiography | 2 | 2010 | 617 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2009 | 3064 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2025 | 463 | 0.050 |
Why?
| | Renal Dialysis | 1 | 2006 | 457 | 0.050 |
Why?
| | Candida | 1 | 2022 | 41 | 0.050 |
Why?
| | Choline | 1 | 2023 | 131 | 0.050 |
Why?
| | HLA-B15 Antigen | 2 | 2012 | 12 | 0.050 |
Why?
| | Insulins | 1 | 2022 | 37 | 0.050 |
Why?
| | Homeodomain Proteins | 1 | 2005 | 512 | 0.050 |
Why?
| | Prenatal Care | 1 | 2004 | 301 | 0.050 |
Why?
| | Electrochemistry | 1 | 2021 | 74 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 362 | 0.040 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2021 | 17 | 0.040 |
Why?
| | Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 45 | 0.040 |
Why?
| | China | 1 | 2021 | 220 | 0.040 |
Why?
| | Immunoglobulin D | 1 | 2021 | 30 | 0.040 |
Why?
| | Serologic Tests | 1 | 2021 | 54 | 0.040 |
Why?
| | Retrospective Studies | 5 | 2025 | 16315 | 0.040 |
Why?
| | Protein Interaction Mapping | 1 | 2021 | 103 | 0.040 |
Why?
| | p-Aminohippuric Acid | 1 | 2020 | 5 | 0.040 |
Why?
| | Fungi | 1 | 2022 | 152 | 0.040 |
Why?
| | Perception | 1 | 2023 | 375 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 113 | 0.040 |
Why?
| | Iohexol | 1 | 2020 | 22 | 0.040 |
Why?
| | Furosemide | 1 | 2020 | 36 | 0.040 |
Why?
| | Isotopes | 1 | 2020 | 34 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2017 | 766 | 0.040 |
Why?
| | Dehydroascorbic Acid | 1 | 2020 | 6 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 146 | 0.040 |
Why?
| | Models, Statistical | 3 | 2015 | 667 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2006 | 677 | 0.040 |
Why?
| | Growth Charts | 1 | 2020 | 15 | 0.040 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2020 | 36 | 0.040 |
Why?
| | Antibody Diversity | 1 | 2019 | 16 | 0.040 |
Why?
| | Antibodies, Heterophile | 1 | 1999 | 13 | 0.040 |
Why?
| | Glucose Transporter Type 2 | 1 | 2019 | 15 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 182 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 123 | 0.040 |
Why?
| | Haemophilus influenzae type b | 1 | 1999 | 12 | 0.040 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 27 | 0.040 |
Why?
| | Viral Proteins | 2 | 2006 | 369 | 0.040 |
Why?
| | Salaries and Fringe Benefits | 1 | 2020 | 56 | 0.040 |
Why?
| | Femur Neck | 1 | 2020 | 63 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2022 | 197 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 76 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2020 | 169 | 0.040 |
Why?
| | Haemophilus Vaccines | 1 | 1999 | 30 | 0.040 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2019 | 47 | 0.040 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 1999 | 28 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 605 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2021 | 287 | 0.040 |
Why?
| | Proline | 1 | 2020 | 80 | 0.040 |
Why?
| | Hepatitis B Vaccines | 1 | 1999 | 43 | 0.040 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2019 | 28 | 0.040 |
Why?
| | Efficiency | 1 | 2020 | 101 | 0.040 |
Why?
| | Alanine | 1 | 2020 | 158 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2019 | 136 | 0.040 |
Why?
| | Methionine | 1 | 2020 | 159 | 0.040 |
Why?
| | Depression | 1 | 2009 | 1487 | 0.040 |
Why?
| | Pediatricians | 1 | 2020 | 131 | 0.040 |
Why?
| | Texas | 2 | 2014 | 262 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 554 | 0.040 |
Why?
| | Maternal Behavior | 1 | 1999 | 80 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 189 | 0.040 |
Why?
| | Immunoglobulin E | 1 | 2021 | 331 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 415 | 0.040 |
Why?
| | Receptor, Insulin | 1 | 1999 | 94 | 0.040 |
Why?
| | Proteobacteria | 1 | 2018 | 16 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 593 | 0.040 |
Why?
| | Adenoviridae | 1 | 2019 | 200 | 0.040 |
Why?
| | beta 2-Microglobulin | 1 | 2018 | 49 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2021 | 335 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 310 | 0.040 |
Why?
| | Pets | 1 | 2018 | 27 | 0.040 |
Why?
| | Down-Regulation | 1 | 2021 | 638 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2000 | 232 | 0.040 |
Why?
| | Emotional Adjustment | 1 | 2018 | 18 | 0.040 |
Why?
| | Lipocalin-2 | 1 | 2018 | 79 | 0.040 |
Why?
| | Microscopy, Polarization | 1 | 2018 | 31 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 60 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 250 | 0.040 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 42 | 0.040 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2020 | 195 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 418 | 0.030 |
Why?
| | Postpartum Period | 1 | 2021 | 343 | 0.030 |
Why?
| | Employment | 1 | 2020 | 179 | 0.030 |
Why?
| | Pelvic Bones | 1 | 2020 | 129 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2018 | 167 | 0.030 |
Why?
| | Apolipoprotein A-I | 1 | 1997 | 30 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2020 | 248 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2898 | 0.030 |
Why?
| | Loss of Function Mutation | 1 | 2017 | 46 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 142 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2017 | 37 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 460 | 0.030 |
Why?
| | Bicarbonates | 1 | 2017 | 45 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2018 | 364 | 0.030 |
Why?
| | Feasibility Studies | 2 | 2015 | 1022 | 0.030 |
Why?
| | Canada | 1 | 2018 | 419 | 0.030 |
Why?
| | Vitamin E | 1 | 1997 | 123 | 0.030 |
Why?
| | Galactosamine | 1 | 2016 | 3 | 0.030 |
Why?
| | Receptor, ErbB-3 | 1 | 2017 | 46 | 0.030 |
Why?
| | Biopsy, Needle | 2 | 2011 | 187 | 0.030 |
Why?
| | Lipoprotein(a) | 1 | 1997 | 68 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2018 | 516 | 0.030 |
Why?
| | Acetylglucosamine | 1 | 2016 | 13 | 0.030 |
Why?
| | Longevity | 1 | 2018 | 175 | 0.030 |
Why?
| | Molecular Weight | 2 | 2012 | 327 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.030 |
Why?
| | United Kingdom | 1 | 2018 | 319 | 0.030 |
Why?
| | Africa | 2 | 1996 | 115 | 0.030 |
Why?
| | Rotavirus Vaccines | 1 | 2016 | 42 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 628 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2017 | 77 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2018 | 498 | 0.030 |
Why?
| | Anemia, Sickle Cell | 1 | 2000 | 266 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 1076 | 0.030 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2017 | 151 | 0.030 |
Why?
| | Vitreoretinopathy, Proliferative | 1 | 2016 | 14 | 0.030 |
Why?
| | Antibody Affinity | 1 | 2016 | 60 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 303 | 0.030 |
Why?
| | Genetic Background | 1 | 2015 | 12 | 0.030 |
Why?
| | Organ Specificity | 2 | 2007 | 311 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 713 | 0.030 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 80 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2013 | 1271 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 1998 | 501 | 0.030 |
Why?
| | Analysis of Variance | 3 | 2010 | 1313 | 0.030 |
Why?
| | Quality of Life | 2 | 2024 | 3005 | 0.030 |
Why?
| | Georgia | 1 | 2015 | 85 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 508 | 0.030 |
Why?
| | Genes | 1 | 1995 | 229 | 0.030 |
Why?
| | Radioligand Assay | 2 | 2009 | 37 | 0.030 |
Why?
| | Florida | 1 | 2015 | 116 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 308 | 0.030 |
Why?
| | Smoking Cessation | 1 | 2019 | 431 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 737 | 0.030 |
Why?
| | Washington | 1 | 2015 | 159 | 0.030 |
Why?
| | Solubility | 1 | 2015 | 244 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 670 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 323 | 0.030 |
Why?
| | Airway Management | 1 | 2015 | 71 | 0.030 |
Why?
| | Insulin, Long-Acting | 2 | 2005 | 64 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 391 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 145 | 0.030 |
Why?
| | Tunica Intima | 3 | 2000 | 76 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 138 | 0.030 |
Why?
| | Hospitalization | 1 | 2004 | 2261 | 0.030 |
Why?
| | Insulin Glargine | 2 | 2005 | 84 | 0.030 |
Why?
| | Achievement | 1 | 2014 | 60 | 0.030 |
Why?
| | Epidemiologic Factors | 1 | 2013 | 10 | 0.030 |
Why?
| | Family Characteristics | 1 | 2015 | 191 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 1 | 2013 | 54 | 0.030 |
Why?
| | Plaque, Atherosclerotic | 1 | 2014 | 58 | 0.030 |
Why?
| | Base Sequence | 2 | 2011 | 2169 | 0.030 |
Why?
| | Complement C1 Inactivator Proteins | 1 | 2012 | 6 | 0.020 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2012 | 11 | 0.020 |
Why?
| | Asthma | 1 | 2025 | 1919 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2015 | 306 | 0.020 |
Why?
| | S100 Calcium Binding Protein beta Subunit | 1 | 2012 | 7 | 0.020 |
Why?
| | Albumins | 1 | 2013 | 114 | 0.020 |
Why?
| | Niacinamide | 1 | 1993 | 82 | 0.020 |
Why?
| | S100 Proteins | 1 | 2012 | 36 | 0.020 |
Why?
| | Nurses | 1 | 2015 | 182 | 0.020 |
Why?
| | California | 2 | 2004 | 455 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2015 | 288 | 0.020 |
Why?
| | Vaccines, Inactivated | 1 | 2012 | 68 | 0.020 |
Why?
| | Biometry | 1 | 1993 | 70 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1658 | 0.020 |
Why?
| | Luciferases | 1 | 2012 | 148 | 0.020 |
Why?
| | Aging | 3 | 2000 | 1917 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2012 | 153 | 0.020 |
Why?
| | Genome | 1 | 2014 | 302 | 0.020 |
Why?
| | Nerve Growth Factors | 1 | 2012 | 78 | 0.020 |
Why?
| | Nitrates | 1 | 1992 | 96 | 0.020 |
Why?
| | Water Supply | 1 | 1992 | 86 | 0.020 |
Why?
| | Diagnostic Techniques, Endocrine | 1 | 2011 | 14 | 0.020 |
Why?
| | Observation | 1 | 2011 | 56 | 0.020 |
Why?
| | 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1998 | 915 | 0.020 |
Why?
| | Potassium Channels | 1 | 2012 | 148 | 0.020 |
Why?
| | Abdominal Fat | 1 | 2012 | 41 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2012 | 159 | 0.020 |
Why?
| | Phylogeny | 2 | 2006 | 1005 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2014 | 367 | 0.020 |
Why?
| | Ubiquitins | 1 | 2011 | 38 | 0.020 |
Why?
| | Diagnosis, Differential | 2 | 2011 | 1491 | 0.020 |
Why?
| | Insulinoma | 1 | 2011 | 27 | 0.020 |
Why?
| | Iodine Radioisotopes | 1 | 2011 | 143 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 335 | 0.020 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2011 | 24 | 0.020 |
Why?
| | Societies, Medical | 1 | 2015 | 852 | 0.020 |
Why?
| | Causality | 1 | 1991 | 131 | 0.020 |
Why?
| | Peptide Fragments | 2 | 2007 | 698 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2015 | 553 | 0.020 |
Why?
| | Leptin | 1 | 2012 | 238 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2852 | 0.020 |
Why?
| | Endothelium, Vascular | 2 | 2008 | 949 | 0.020 |
Why?
| | Radioimmunoprecipitation Assay | 1 | 2009 | 6 | 0.020 |
Why?
| | Microchemistry | 1 | 2009 | 19 | 0.020 |
Why?
| | Staphylococcal Protein A | 1 | 2009 | 14 | 0.020 |
Why?
| | Biostatistics | 1 | 2009 | 18 | 0.020 |
Why?
| | DNA Replication | 1 | 2011 | 239 | 0.020 |
Why?
| | Cholera Toxin | 1 | 2009 | 31 | 0.020 |
Why?
| | Fetal Weight | 1 | 2009 | 54 | 0.020 |
Why?
| | Graves Disease | 1 | 2009 | 34 | 0.020 |
Why?
| | Intra-Abdominal Fat | 1 | 2010 | 89 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7899 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 152 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 396 | 0.020 |
Why?
| | Pancreatic Polypeptide | 1 | 1989 | 4 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2009 | 92 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 521 | 0.020 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2008 | 29 | 0.020 |
Why?
| | Radiography | 1 | 2011 | 844 | 0.020 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2008 | 46 | 0.020 |
Why?
| | Tunica Media | 2 | 2000 | 36 | 0.020 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2008 | 21 | 0.020 |
Why?
| | Survival Rate | 2 | 2006 | 1962 | 0.020 |
Why?
| | Protein Precursors | 1 | 2009 | 134 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 140 | 0.020 |
Why?
| | Telecommunications | 1 | 1988 | 21 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2009 | 196 | 0.020 |
Why?
| | Vaccination | 1 | 2017 | 1467 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2008 | 30 | 0.020 |
Why?
| | Nutrition Therapy | 1 | 2008 | 35 | 0.020 |
Why?
| | Glucagon | 1 | 1989 | 104 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 985 | 0.020 |
Why?
| | Pacific Islands | 1 | 1988 | 3 | 0.020 |
Why?
| | Solanum tuberosum | 1 | 2008 | 7 | 0.020 |
Why?
| | Outpatients | 1 | 1992 | 418 | 0.020 |
Why?
| | Probability | 1 | 1989 | 308 | 0.020 |
Why?
| | Americas | 1 | 1988 | 26 | 0.020 |
Why?
| | Diabetic Neuropathies | 1 | 2009 | 94 | 0.020 |
Why?
| | Asia | 1 | 1988 | 68 | 0.020 |
Why?
| | Pregnancy in Diabetics | 1 | 2009 | 124 | 0.020 |
Why?
| | Survival | 1 | 2007 | 39 | 0.020 |
Why?
| | Bottle Feeding | 1 | 2007 | 20 | 0.020 |
Why?
| | Carotenoids | 1 | 2007 | 42 | 0.020 |
Why?
| | Vegetables | 1 | 2008 | 161 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 184 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1726 | 0.020 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2006 | 47 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2006 | 59 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2006 | 72 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2006 | 56 | 0.020 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2006 | 63 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2013 | 1471 | 0.020 |
Why?
| | Serotyping | 1 | 2005 | 33 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2006 | 363 | 0.010 |
Why?
| | Self Care | 1 | 2009 | 392 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2822 | 0.010 |
Why?
| | Species Specificity | 1 | 2006 | 577 | 0.010 |
Why?
| | Alprostadil | 1 | 2005 | 32 | 0.010 |
Why?
| | Cause of Death | 2 | 2002 | 441 | 0.010 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2005 | 132 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2004 | 11125 | 0.010 |
Why?
| | Puerto Rico | 1 | 2004 | 54 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 374 | 0.010 |
Why?
| | Ultrasonography | 2 | 2000 | 760 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 639 | 0.010 |
Why?
| | Dinoprostone | 1 | 2005 | 189 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2004 | 125 | 0.010 |
Why?
| | Genome, Viral | 1 | 2005 | 223 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 2003 | 93 | 0.010 |
Why?
| | Regeneration | 1 | 2005 | 199 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 3999 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 289 | 0.010 |
Why?
| | Insulin Lispro | 1 | 2003 | 42 | 0.010 |
Why?
| | DNA, Viral | 1 | 2005 | 363 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2176 | 0.010 |
Why?
| | Guidelines as Topic | 1 | 2005 | 268 | 0.010 |
Why?
| | Duodenum | 1 | 2003 | 74 | 0.010 |
Why?
| | Health | 1 | 2003 | 83 | 0.010 |
Why?
| | Income | 1 | 2003 | 198 | 0.010 |
Why?
| | HLA-A Antigens | 1 | 2002 | 57 | 0.010 |
Why?
| | Models, Immunological | 1 | 2002 | 101 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 210 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2008 | 4199 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2000 | 75 | 0.010 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 44 | 0.010 |
Why?
| | Carotid Artery, Common | 1 | 2000 | 30 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 1985 | 509 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 274 | 0.010 |
Why?
| | Cholesterol, VLDL | 1 | 1999 | 5 | 0.010 |
Why?
| | Acute Disease | 1 | 2002 | 1010 | 0.010 |
Why?
| | Genetic Counseling | 1 | 1999 | 81 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5148 | 0.010 |
Why?
| | Twins, Dizygotic | 1 | 1999 | 163 | 0.010 |
Why?
| | Twins, Monozygotic | 1 | 1999 | 190 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 1998 | 167 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 273 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 2006 | 1178 | 0.010 |
Why?
| | Demography | 1 | 1998 | 295 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2604 | 0.010 |
Why?
| | Quantitative Trait, Heritable | 1 | 1997 | 124 | 0.010 |
Why?
| | Cholesterol, LDL | 1 | 1998 | 360 | 0.010 |
Why?
| | Bacterial Infections | 1 | 1998 | 245 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 414 | 0.010 |
Why?
| | Mexico | 1 | 1996 | 229 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2000 | 2522 | 0.010 |
Why?
| | Mental Disorders | 1 | 2002 | 1123 | 0.010 |
Why?
| | Baltic States | 1 | 1992 | 1 | 0.010 |
Why?
| | Energy Metabolism | 1 | 1998 | 930 | 0.010 |
Why?
| | Rats | 1 | 2000 | 5594 | 0.010 |
Why?
| | Geography | 1 | 1992 | 199 | 0.010 |
Why?
| | Software | 1 | 1997 | 676 | 0.010 |
Why?
| | Cohort Effect | 1 | 1990 | 4 | 0.010 |
Why?
| | Periodicity | 1 | 1990 | 56 | 0.010 |
Why?
| | Space-Time Clustering | 1 | 1989 | 3 | 0.000 |
Why?
| | Actuarial Analysis | 1 | 1989 | 22 | 0.000 |
Why?
| | Coxsackievirus Infections | 1 | 1987 | 14 | 0.000 |
Why?
| | Rubella | 1 | 1987 | 23 | 0.000 |
Why?
| | Mortality | 1 | 1989 | 359 | 0.000 |
Why?
| | Neoplasms | 1 | 1989 | 2718 | 0.000 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|